Fusion Pharmaceuticals, part of AstraZeneca, is hiring a Radioconjugate Scientist - IHC at its GMP-compliant radiopharmaceutical facility in Hamilton, Ontario, developing next-generation radioconjugates that deliver alpha-emitting payloads to tumors as part of its precision oncology pipeline.
Text as published by the employer. Always confirm details on the employer's site.